TUG1 and acute myeloid leukemia: Moreover, m6A modification and YTHDF2 enrichment on TUG1 were reduced in AML cells, and further diminished in drug-resistant cells (P < 0.01, Figure 3C), while silencing ALKBH5 enhanced both (P < 0.01, Figure 3C).